Skip to content
Recall Observatory FDA recall evidence

Drug product

SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-130-02

D-0763-2022

March 21, 2022

Class I

Product summary

Firm
Adamis Pharmaceuticals Corporation
Event
Event 89778
Status
Terminated
Classification
Class I
Quantity
25,103 cartons
Official record key
drug-enforcement:D-0763-2022

Official wording

Reason: Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Code information: Lot #: 21041W, Exp. 8/31/2022; 21081W, Exp. 11/30/2022; 21102W, Exp. 2/28/2023

Distribution pattern: Nationwide in the U.S.A.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.